Cargando…
HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors
BACKGROUND: Approximately one in five breast cancers are driven by amplification and overexpression of the human epidermal growth factor receptor 2 (HER2) receptor kinase, and HER2-enriched (HER2E) is one of four major transcriptional subtypes of breast cancer. We set out to understand the genomics...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791377/ https://www.ncbi.nlm.nih.gov/pubmed/29382369 http://dx.doi.org/10.1186/s13058-018-0933-y |